Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Román González-Prieto
LAB HEAD: Alfred C.O. Vertegaal
PROVIDER: PXD013161 | Pride | 2020-01-29
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
DUB-profilingresult.zip | Other | |||
Samplenumbering.xlsx | Xlsx | |||
q101920-result.zip | Other | |||
q101920a.raw | Raw | |||
q102592a.raw | Raw |
Items per page: 5 1 - 5 of 84 |
Liu Sijia S González-Prieto Román R Zhang Mengdi M Geurink Paul P PP Kooij Raymond R Iyengar Prasanna Vasudevan PV van Dinther Maarten M Bos Erik E Zhang Xiaobing X Le Dévédec Sylvia E SE van de Water Bob B Koning Roman I RI Zhu Hong-Jian HJ Mesker Wilma E WE Vertegaal Alfred C O ACO Ovaa Huib H Zhang Long L Martens John W M JWM Ten Dijke Peter P
Clinical cancer research : an official journal of the American Association for Cancer Research 20191219 6
<h4>Purpose</h4>Therapies directed to specific molecular targets are still unmet for patients with triple-negative breast cancer (TNBC). Deubiquitinases (DUB) are emerging drug targets. The identification of highly active DUBs in TNBC may lead to novel therapies.<h4>Experimental design</h4>Using DUB activity probes, we profiled global DUB activities in 52 breast cancer cell lines and 52 patients' tumor tissues. To validate our findings <i>in vivo</i>, we employed both zebrafish and murine breast ...[more]